{"entity":{"type":"insider","cik":"0002050172","url":"/insider/0002050172","json_url":"/insider/0002050172.json","name":"Bernstein Harold","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":23,"n_filings":11,"first":"2025-12-31","last":"2026-08-14","span_basis":"filed_date"},"name_variants":[{"name":"Bernstein Harold","source":"filing","n_filings":11,"first_seen":"2025-12-31","last_seen":"2026-08-14"}],"transactions":[{"id":9297114,"accession":"0002050172-26-000028","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0002050172-26-000028","line_url":"/filing/0002050172-26-000028#line-1","is_derivative":false,"issuer_cik":"0002050172","issuer_name":"Maze Therapeutics, Inc.","issuer_ticker":"MAZE","issuer_name_source":null,"issuer_url":"/issuer/0002050172","owner_cik":"0002050172","owner_name":"Bernstein Harold","owner_display_name":"Bernstein Harold","owner_url":"/insider/0002050172","role":"Officer (President, R&D & CMO)","role_mark":"O","role_mark_label":"Officer (President, R&D & CMO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President, R&D & CMO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":16142.0,"shares_display":"16,142","price_per_share":27.6063,"price_display":"27.61","price_state":"stated","total_value":445620.8946,"total_display":"445,620.89","total_whole":"445,621","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-08-13","filed_date":"2026-08-14","scope":"insider"},{"id":5754876,"accession":"0002050172-26-000025","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0002050172-26-000025","line_url":"/filing/0002050172-26-000025","is_derivative":false,"issuer_cik":"0001842295","issuer_name":"Maze Therapeutics, Inc.","issuer_ticker":"MAZE","issuer_name_source":null,"issuer_url":"/issuer/0001842295","owner_cik":"0002050172","owner_name":"Bernstein Harold","owner_display_name":"Bernstein Harold","owner_url":"/insider/0002050172","role":"Officer (President, R&D & CMO)","role_mark":"O","role_mark_label":"Officer (President, R&D & CMO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President, R&D & CMO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":14609.0,"shares_display":"14,609","price_per_share":29.903762406735574,"price_display":"29.90","price_state":"stated","total_value":436864.065,"total_display":"436,864.06","total_whole":"436,864","shares_owned_after":1200.0,"shares_owned_after_display":"1,200","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-07-01","filed_date":"2026-07-02","scope":"insider","n_lines":2},{"id":6143735,"accession":"0002050172-26-000023","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0002050172-26-000023","line_url":"/filing/0002050172-26-000023","is_derivative":false,"issuer_cik":"0001842295","issuer_name":"Maze Therapeutics, Inc.","issuer_ticker":"MAZE","issuer_name_source":null,"issuer_url":"/issuer/0001842295","owner_cik":"0002050172","owner_name":"Bernstein Harold","owner_display_name":"Bernstein Harold","owner_url":"/insider/0002050172","role":"Officer (President, R&D & CMO)","role_mark":"O","role_mark_label":"Officer (President, R&D & CMO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President, R&D & CMO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":14853.0,"shares_display":"14,853","price_per_share":25.65894659664714,"price_display":"25.66","price_state":"stated","total_value":381112.3338,"total_display":"381,112.33","total_whole":"381,112","shares_owned_after":1600.0,"shares_owned_after_display":"1,600","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-06-01","filed_date":"2026-06-03","scope":"insider","n_lines":2},{"id":5972845,"accession":"0002050172-26-000021","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0002050172-26-000021","line_url":"/filing/0002050172-26-000021#line-2","is_derivative":false,"issuer_cik":"0001842295","issuer_name":"Maze Therapeutics, Inc.","issuer_ticker":"MAZE","issuer_name_source":null,"issuer_url":"/issuer/0001842295","owner_cik":"0002050172","owner_name":"Bernstein Harold","owner_display_name":"Bernstein Harold","owner_url":"/insider/0002050172","role":"Officer (President, R&D & CMO)","role_mark":"O","role_mark_label":"Officer (President, R&D & CMO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President, R&D & CMO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":15000.0,"shares_display":"15,000","price_per_share":26.2236,"price_display":"26.22","price_state":"stated","total_value":393354.0,"total_display":"393,354.00","total_whole":"393,354","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-05-14","filed_date":"2026-05-18","scope":"insider"},{"id":6122274,"accession":"0002050172-26-000019","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0002050172-26-000019","line_url":"/filing/0002050172-26-000019","is_derivative":false,"issuer_cik":"0001842295","issuer_name":"Maze Therapeutics, Inc.","issuer_ticker":"MAZE","issuer_name_source":null,"issuer_url":"/issuer/0001842295","owner_cik":"0002050172","owner_name":"Bernstein Harold","owner_display_name":"Bernstein Harold","owner_url":"/insider/0002050172","role":"Officer (President, R&D & CMO)","role_mark":"O","role_mark_label":"Officer (President, R&D & CMO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President, R&D & CMO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":15000.0,"shares_display":"15,000","price_per_share":29.46028272,"price_display":"29.46","price_state":"stated","total_value":441904.2408,"total_display":"441,904.24","total_whole":"441,904","shares_owned_after":3648.0,"shares_owned_after_display":"3,648","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-04-01","filed_date":"2026-04-02","scope":"insider","n_lines":3},{"id":6049524,"accession":"0002050172-26-000017","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0002050172-26-000017","line_url":"/filing/0002050172-26-000017","is_derivative":false,"issuer_cik":"0001842295","issuer_name":"Maze Therapeutics, Inc.","issuer_ticker":"MAZE","issuer_name_source":null,"issuer_url":"/issuer/0001842295","owner_cik":"0002050172","owner_name":"Bernstein Harold","owner_display_name":"Bernstein Harold","owner_url":"/insider/0002050172","role":"Officer (President, R&D & CMO)","role_mark":"O","role_mark_label":"Officer (President, R&D & CMO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President, R&D & CMO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":15000.0,"shares_display":"15,000","price_per_share":49.09595294,"price_display":"49.10","price_state":"stated","total_value":736439.2941,"total_display":"736,439.29","total_whole":"736,439","shares_owned_after":8839.0,"shares_owned_after_display":"8,839","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-03-20","filed_date":"2026-03-20","scope":"insider","n_lines":3},{"id":5972841,"accession":"0002050172-26-000015","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0002050172-26-000015","line_url":"/filing/0002050172-26-000015","is_derivative":false,"issuer_cik":"0001842295","issuer_name":"Maze Therapeutics, Inc.","issuer_ticker":"MAZE","issuer_name_source":null,"issuer_url":"/issuer/0001842295","owner_cik":"0002050172","owner_name":"Bernstein Harold","owner_display_name":"Bernstein Harold","owner_url":"/insider/0002050172","role":"Officer (President, R&D & CMO)","role_mark":"O","role_mark_label":"Officer (President, R&D & CMO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President, R&D & CMO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":30000.0,"shares_display":"30,000","price_per_share":50.45200736,"price_display":"50.45","price_state":"stated","total_value":1513560.2208,"total_display":"1,513,560.22","total_whole":"1,513,560","shares_owned_after":348.0,"shares_owned_after_display":"348","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-03-10","filed_date":"2026-03-12","scope":"insider","n_lines":2},{"id":5878098,"accession":"0002050172-26-000009","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0002050172-26-000009","line_url":"/filing/0002050172-26-000009","is_derivative":false,"issuer_cik":"0001842295","issuer_name":"Maze Therapeutics, Inc.","issuer_ticker":"MAZE","issuer_name_source":null,"issuer_url":"/issuer/0001842295","owner_cik":"0002050172","owner_name":"Bernstein Harold","owner_display_name":"Bernstein Harold","owner_url":"/insider/0002050172","role":"Officer (President, R&D & CMO)","role_mark":"O","role_mark_label":"Officer (President, R&D & CMO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President, R&D & CMO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":15000.0,"shares_display":"15,000","price_per_share":46.02224984,"price_display":"46.02","price_state":"stated","total_value":690333.7476,"total_display":"690,333.75","total_whole":"690,334","shares_owned_after":6036.0,"shares_owned_after_display":"6,036","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-02-02","filed_date":"2026-02-04","scope":"insider","n_lines":4},{"id":5952709,"accession":"0002050172-26-000006","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0002050172-26-000006","line_url":"/filing/0002050172-26-000006#line-2","is_derivative":false,"issuer_cik":"0001842295","issuer_name":"Maze Therapeutics, Inc.","issuer_ticker":"MAZE","issuer_name_source":null,"issuer_url":"/issuer/0001842295","owner_cik":"0002050172","owner_name":"Bernstein Harold","owner_display_name":"Bernstein Harold","owner_url":"/insider/0002050172","role":"Officer (President, R&D & CMO)","role_mark":"O","role_mark_label":"Officer (President, R&D & CMO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President, R&D & CMO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":25156.0,"shares_display":"25,156","price_per_share":40.2011,"price_display":"40.20","price_state":"stated","total_value":1011298.8716,"total_display":"1,011,298.87","total_whole":"1,011,299","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-01-07","filed_date":"2026-01-09","scope":"insider"},{"id":5754871,"accession":"0002050172-26-000003","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0002050172-26-000003","line_url":"/filing/0002050172-26-000003#line-4","is_derivative":false,"issuer_cik":"0001842295","issuer_name":"Maze Therapeutics, Inc.","issuer_ticker":"MAZE","issuer_name_source":null,"issuer_url":"/issuer/0001842295","owner_cik":"0002050172","owner_name":"Bernstein Harold","owner_display_name":"Bernstein Harold","owner_url":"/insider/0002050172","role":"Officer (President, R&D & CMO)","role_mark":"O","role_mark_label":"Officer (President, R&D & CMO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President, R&D & CMO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":412.0,"shares_display":"412","price_per_share":40.0,"price_display":"40.00","price_state":"stated","total_value":16480.0,"total_display":"16,480.00","total_whole":"16,480","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-01-05","filed_date":"2026-01-06","scope":"insider"},{"id":5754867,"accession":"0002050172-26-000003","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0002050172-26-000003","line_url":"/filing/0002050172-26-000003#line-2","is_derivative":false,"issuer_cik":"0001842295","issuer_name":"Maze Therapeutics, Inc.","issuer_ticker":"MAZE","issuer_name_source":null,"issuer_url":"/issuer/0001842295","owner_cik":"0002050172","owner_name":"Bernstein Harold","owner_display_name":"Bernstein Harold","owner_url":"/insider/0002050172","role":"Officer (President, R&D & CMO)","role_mark":"O","role_mark_label":"Officer (President, R&D & CMO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President, R&D & CMO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4432.0,"shares_display":"4,432","price_per_share":40.4304,"price_display":"40.43","price_state":"stated","total_value":179187.5328,"total_display":"179,187.53","total_whole":"179,188","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-01-02","filed_date":"2026-01-06","scope":"insider"},{"id":4216478,"accession":"0002050172-25-000007","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0002050172-25-000007","line_url":"/filing/0002050172-25-000007","is_derivative":false,"issuer_cik":"0001842295","issuer_name":"Maze Therapeutics, Inc.","issuer_ticker":"MAZE","issuer_name_source":null,"issuer_url":"/issuer/0001842295","owner_cik":"0002050172","owner_name":"Bernstein Harold","owner_display_name":"Bernstein Harold","owner_url":"/insider/0002050172","role":"Officer (President, R&D & CMO)","role_mark":"O","role_mark_label":"Officer (President, R&D & CMO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President, R&D & CMO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":45000.0,"shares_display":"45,000","price_per_share":40.56344088888889,"price_display":"40.56","price_state":"stated","total_value":1825354.84,"total_display":"1,825,354.84","total_whole":"1,825,355","shares_owned_after":17200.0,"shares_owned_after_display":"17,200","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-12-29","filed_date":"2025-12-31","scope":"insider","n_lines":2}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":23,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":23,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":23},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001842295","name":"Maze Therapeutics, Inc.","url":"/issuer/0001842295","role":"Officer (President, R&D & CMO)","n_filings":11,"first_seen":"2025-12-31","last_seen":"2026-08-14"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0002050172","retrieved_at":"2026-08-27T10:09:04+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-26","last_ingest":"2026-08-27T05:24:39.644631+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}